Deltex Medical Receives Innovative Technology Contract From Major US Healthcare Consultancy

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has received an Innovative Technology contract from Vizient, Inc., the largest member-driven healthcare performance improvement company in the…

Oesophageal Doppler Features Strongly in Updated Cancer Surgery Guidance

The UK’s National Institute for Health and Care Excellence (NICE) has updated its guidance for practitioners in the management of colorectal cancer. NICE publishes it’s so-called “pathways” in order to…

Deltex Medical’s Haemodynamic Management Tools at Euroanaesthesia

This weekend sees Vienna hosting the annual Euroanaesthesia event, recognised worldwide as one of the most important and influential congresses in anaesthesiology. With over 6000 international delegates and 100+ exhibitors from…

Deltex CEO Andy Mears to present at Turner Pope investment evening, May 13

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), is pleased to announce that Andy Mears, the Company’s Chief Executive Officer, will be presenting at an investor evening…

Deltex Medical 2018 Results

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has announced its audited results for the year ended 31 December 2018. Find the link to the…

Pre-Close Statement and Trading Update

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has published a pre-close statement in relation to the year ended 31 December 2018. The Group has…

NICE Recommends ODM in Trauma Patients with Major Haemorrhaging

The UK’s National Institute for Health and Care Excellence (NICE) publishes guidance on many aspects of patient care. These documents are often collated into treatment pathways, bringing together everything NICE…

29 Years and Counting: Mears and the Haemodynamic Management Mission

Speaking from the heart, Andy Mears CEO of Deltex says “Thanks to LinkedIn for kindly pointing out that I am celebrating 29 years at Deltex Medical this month. Thanks also…

Show Time for Deltex with US Launch of TrueVue at ASA

October 13th sees the start of this year’s Anesthesiology Society of America (ASA) annual congress in San Francisco. Deltex will be exhibiting at this major event (booth 1513), launching its…

Journal Spells it Out: Haemodynamic Management Matters

October’s Clinical Services Journal includes an article that should be essential reading for the anaesthetist who wants to deliver optimal care. That’s because it gets down to the bare bones…